BDNF and infection: An explanation for the opposite trends in BDNF levels shown in the study of Correale and ours may be several differences in study design: e.g. relapsing-remitting vs. secondary progressive MS, stimulated B cells vs. serum levels, natural infections vs. experimental TSO treatment, clinical observational vs. prospective clinical trial study design.